Skip to main content
. 2020 May 29;15(5):e0233527. doi: 10.1371/journal.pone.0233527

Table 1. Demographic and questionnaire outcomes from men with Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) who experienced at least weekly urinary incontinence (incontinent) or no incontinence (continent).

All Continent Incontinent
n 27 17 10
DMD/BMD 11/16 10/7 4/6
Age (years) 31.4 (9.6) 30.5 (10.5) 32.9 (8.2)
Brooke 6 (1–6) 5 (1–6) 6 (1–6)
Vignos 9 (2–9) 9 (2–9) 9 (2–9)
BI (-UI) 5.9 (6.0) 6.2 (6.0) 5.3 (6.3)
ICIQ Total 2.1 (3.2) 0.4 (1.5) 5.8 (2.6)
ICIQ Interference 0.7 (1.5) 0 (0) 2.0 (1.9)
IIQ-7_SF 6.2 (10.8) 0.8 (3.4) 15.3 (13.1)
IIQ Physical 1.9 (7.1) 0 (0) 5.0 (11.2)
IIQ Travel 5.6 (13.1) 2.0 (8.1) 11.7 (17.7)*
IIQ Social 9.9 (20.3) 2.0 (8.1) 23.3 (27.4)*
IIQ Emotional 9.3 (17.5) 0 (0) 25.0 (21.0)
UDI-6 12.1 (12.8) 5.2 (7.4) 20.8 (13.0)
NBD 3.52 (3.95) 3.18 (3.54) 4.10 (4.70)

Questionnaires include: The Barthel index (BI) of disability (-UI, minus urinary incontinence score), International Consultation on Incontinence Questionnaire—Urinary Incontinence Form (ICIQ-UI_SF), Incontinence Impact Questionnaire Short Form (IIQ-7_SF), The Urogenital Distress Inventory (UDI-6), and The Neurogenic bowel dysfunction (NBD) score. Data are median (minimum-maximum), or mean (SD).

* and denotes significant difference from Continent participants, P<0.05 and P<0.01, respectively.